J. Colombel

发表

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Judy H. Cho, John P. Ferguson, G. Wainrib, 2019, Scientific Reports.

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

Tariq Ahmad, Albert Cohen, Judy H Cho, 2010, Nature Genetics.

The efficacy and safety of a third anti‐TNF monoclonal antibody in Crohn’s disease after failure of two other anti‐TNF antibodies

P. Rutgeerts, S. Vermeire, G. Van Assche, 2010, Alimentary pharmacology & therapeutics.

Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease

J. Belaiche, P. Rutgeerts, S. Vermeire, 2004, Alimentary pharmacology & therapeutics.

Use of anti-tumour necrosis factor agents in inflammatory bowel disease

A. Forbes, M. Vatn, P. Rutgeerts, 2001, International Journal of Colorectal Disease.

Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus

S. Travis, J. Mary, L. Peyrin-Biroulet, 2017, Alimentary pharmacology & therapeutics.

Adalimumab sustains steroid‐free remission after 3 years of therapy for Crohn’s disease

M. Kamm, Qian Zhou, W. Sandborn, 2011, Alimentary pharmacology & therapeutics.

Treatment of severe Crohn's disease with anti‐CD4 monoclonal antibody

R. Modigliani, E. Robinet, J. Revillard, 1996, Alimentary pharmacology & therapeutics.

Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn's Disease: A French Population-Based Study.

J. Ledent, P. Varlet, I. Iwanicki-Caron, 2018, Inflammatory bowel diseases.

Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine

J. Belaiche, B. Bonaz, B. Flourié, 2003, Alimentary pharmacology & therapeutics.

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Judy H. Cho, John P. Ferguson, G. Wainrib, 2019, Scientific Reports.

Factors associated with pregnancy outcome in anti‐TNF treated women with inflammatory bowel disease

A. Amiot, B. Bonaz, M. De Vos, 2014, Alimentary pharmacology & therapeutics.

Anti‐Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features

A. Andriulli, A. Piepoli, A. Latiano, 2004, Alimentary pharmacology & therapeutics.

Development and validation of a patient‐reported disability measurement tool for patients with inflammatory bowel disease

M. Kamm, L. Peyrin-Biroulet, S. Bell, 2013, Alimentary pharmacology & therapeutics.

Impaired contractile response of mesenteric arteries in Crohn’s disease

P. Desreumaux, G. Lebuffe, B. Vallet, 2000, Alimentary pharmacology & therapeutics.

Nodular regenerative hyperplasia with portal hypertension in patients with inflammatory bowel disease treated with azathioprine

M. Vos, W. Reinisch, P. Marteau, 2006 .

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Lisa, Husam, John P. Ferguson, 2023 .

[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Spanish version)].

S. Travis, M. Sans, J. Lindsay, 2015, Revista de gastroenterologia de Mexico.